The Food and Drug Administration issued a purchase order to Creighton University for $154,452.00 on September 23, 2024. This is a no-cost modification extending the period of performance to March 13, 2026. Work is performed in Silver Spring, Maryland. The order funds further investigation of the association between β-lactamase enzyme expression and other proteins and antimicrobial resistance by studying additional gram-negative bacterial isolates. Pricing is firm fixed price with no small...
<p>The Food and Drug Administration issued a purchase order to Yale University valued at $137,780 on September 28, 2022, to collect pathologist annotations. This modification de-obligates excess funds and closes out the contract. Work is performed in Silver Spring, Maryland, with an ultimate completion date of September 28, 2027. The purchase order carries firm fixed price pricing with no set-aside applied.</p>
<p>The Food and Drug Administration issued a purchase order to The Food And Drug Law Institute, Inc. for $18,360 on July 21, 2026, to cover registration and attendance at the FDLI Enforcement, Litigation, and Compliance Conference. Performance occurs in Washington, DC. The order is firm fixed price with a completion date of December 11, 2026.</p>
<p>The Food and Drug Administration awarded a $173,975 definitive contract to Emory University for Executive Order 14398 compliance work on September 6, 2026, under firm fixed-price pricing with no set-aside.</p>
<p>Place of performance is Silver Spring, Maryland. The contract runs through September 5, 2027. The source does not specify the originating solicitation scope or detailed deliverables beyond the EO 14398 reference.</p>
<p>The Food and Drug Administration awarded a purchase order to Dorothy Farrell for $20,000.00 on September 15, 2026. Work is performed in Bowie, Maryland. The order supports the Center for Veterinary Medicine Office of Applied Science in providing non-affiliated member Institutional Animal Care and Use Committee services. The contract carries a firm fixed price and runs through September 14, 2031.</p>
<p>The Food and Drug Administration awarded a purchase order to the American Statistical Association for $45,150 on September 16, 2026, for the EO-14398-ASA Biopharmaceutical Section Regulatory Industry Statistics Workshop. Work is performed in Alexandria, Virginia. The order carries a firm fixed price and completes by September 18, 2026.</p>
<p>The Food and Drug Administration issued a purchase order to Parenteral Drug Association, Inc. for $74,916.00 on September 14, 2026, to support the Parenteral Drug Association/Food and Drug Administration Joint Regulatory Conference 2026 under Executive Order 14398. Place of performance is Washington, DC. The order carries a firm fixed price structure with an ultimate completion date of September 16, 2026. No small business set-aside applies.</p>
<p>The Food and Drug Administration awarded a purchase order to Mpf-Zai Solutions LLC, a woman-owned small business, for $2,001,241.20 on June 1, 2026. Work is performed in Silver Spring, Maryland. The order covers scientific data abstraction and information management services for the Center for Biologics Evaluation and Research (CBER) under firm fixed-price terms. The contract runs through May 31, 2030. No set-aside category applied to this unrestricted award.</p>
The Food and Drug Administration awarded a purchase order to Thinktrends, LLC for software support services valued at $161,530.03, effective September 16, 2025, with completion by September 28, 2026. Work is performed in Silver Spring, Maryland. The order supports the FDA's technology infrastructure on a firm fixed-price basis with no small business set-aside. The originating solicitation, posted July 22, 2025, sought an AI-based Optical Character Recognition solution to extract data from...
<p>The Food and Drug Administration issued a $541,187 delivery order to Eastern Research Group Inc. on September 24, 2025, for updating inputs to the FDA Labeling and Reformulation Cost Models, with a firm fixed-price structure and ultimate completion date of March 28, 2028.</p>
<p>Place of performance is Concord, MA. The order carries no set-aside designation.</p>